• 1211 Citations
  • 18 h-Index
1984 …2019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Delia Rota Scalabrini is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 40 Similar Profiles
Hodgkin Disease Medicine & Life Sciences
Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences
Doxorubicin Medicine & Life Sciences
Cyclophosphamide Medicine & Life Sciences
Vinblastine Medicine & Life Sciences
Prednisone Medicine & Life Sciences
Follicular Lymphoma Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1984 2019

  • 1211 Citations
  • 18 h-Index
  • 39 Article

Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial

Bruna, R., Benedetti, F., Boccomini, C., Patti, C., Barbui, A. M., Pulsoni, A., Musso, M., Liberati, A. M., Gini, G., Castellino, C., Rossini, F., Ciceri, F., Rota-Scalabrini, D., Stelitano, C., Di Raimondo, F., Tucci, A., Devizzi, L., Zoli, V., Zallio, F., Narni, F. & 15 others, Dondi, A., Parvis, G., Semenzato, G., Lanza, F., Perrone, T., Angrilli, F., Billio, A., Gueli, A., Mantoan, B., Rambaldi, A., Massimo Gianni, A., Corradini, P., Passera, R., Ladetto, M. & Tarella, C., Jan 1 2019, In : Haematologica. 104, 11, p. 2241-2248 8 p.

Research output: Contribution to journalArticle

Open Access
Follicular Lymphoma
Immunotherapy
Recurrence
Survival
Drug Therapy
13 Citations (Scopus)

Reduced intensity VEPEMB regimen compared with standard ABVD in elderly Hodgkin lymphoma patients: Results from a randomized trial on behalf of the Fondazione Italiana Linfomi (FIL)

Zallio, F., Tamiazzo, S., Monagheddu, C., Merli, F., Ilariucci, F., Stelitano, C., Liberati, A. M., Mannina, D., Vitolo, U., Angelucci, E., Rota Scalabrini, D., Vallisa, D., Bellei, M., Bari, A., Ciccone, G., Salvi, F. & Levis, A., Mar 1 2016, In : British Journal of Haematology. 172, 6, p. 879-888 10 p.

Research output: Contribution to journalArticle

Dacarbazine
Vinblastine
Bleomycin
Hodgkin Disease
Doxorubicin

Reduced intensity VEPEMB regimen compared with standard ABVD in elderly Hodgkin lymphoma patients: Results from a randomized trial on behalf of the Fondazione Italiana Linfomi (FIL)

Zallio, F., Tamiazzo, S., Monagheddu, C., Merli, F., Ilariucci, F., Stelitano, C., Liberati, A. M., Mannina, D., Vitolo, U., Angelucci, E., Rota Scalabrini, D., Vallisa, D., Bellei, M., Bari, A., Ciccone, G., Salvi, F. & Levis, A., Mar 1 2016, In : British Journal of Haematology. 172, 6, p. 879-888 10 p.

Research output: Contribution to journalArticle

Dacarbazine
Vinblastine
Bleomycin
Hodgkin Disease
Doxorubicin
12 Citations (Scopus)
Bile Ducts
Hodgkin Disease
Ducts
Chemotherapy
Liver
48 Citations (Scopus)

Persistence of minimal residual disease in bone marrow predicts outcome in follicular lymphomas treated with a rituximab-intensive program

Ladetto, M., Lobetti-Bodoni, C., Mantoan, B., Ceccarelli, M., Boccomini, C., Genuardi, E., Chiappella, A., Baldini, L., Rossi, G., Pulsoni, A., Di Raimondo, F., Rigacci, L., Pinto, A., Galimberti, S., Bari, A., Rota-Scalabrini, D., Ferrari, A., Zaja, F., Gallamini, A., Specchia, G. & 5 others, Musto, P., Rossi, F. G., Gamba, E., Evangelista, A. & Vitolo, U., Nov 28 2013, In : Blood. 122, 23, p. 3759-3766 8 p.

Research output: Contribution to journalArticle

Follicular Lymphoma
Residual Neoplasm
Bone
Bone Marrow
Polymerase chain reaction